The European Commission is of the opinion that “there is no longer a need to apply the requirement to produce an export authorisation for Covid-19 vaccines or their active substances after 31 December 2021”, as was formulated in its implementing regulation of Thursday 25 November.
Since 31 January 2021, the European Commission has put in place a mechanism for authorising exports of these vaccines and their active substances. Export companies must obtain the go-ahead from the Member State where they are located and from the Commission before they export doses.
The Commission has decided to end this authorisation system, while still maintaining an export monitoring mechanism. For two years, exporters will have to declare the number of doses of Covid-19 vaccines they have exported along with the active substances they have used to produce them.
This should enable the European Commission to collect statistical data so that they can detect potential non-compliance with the Commission’s advance purchase agreements and anticipate the EU’s capacity to make new vaccine donations.
See the implementing regulation: https://bit.ly/2ZqnDdX (Original version in French by Léa Marchal)